drugset / Trial / NCT07507838
Safety and Pharmacokinetics Study of Multiple Ascending Doses of VV913 Capsules
RandomizedParallel-groupTriple-blindTreatment
Summary
This study is a single-center, randomized, double-blind, placebo-controlled, dose-escalation trial to assess the safety, tolerability, pharmacokinetics （PK） of multiple doses of VV913 in Chinese healthy adult participants.
Timeline
- Start
- 2026-04-13
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VV913 | Unknown | 4 mg | Oral |
| Subject | VV913 | Unknown | 8 mg | Oral |
| Subject | VV913 | Unknown | 15 mg | Oral |
Indications
No indication recorded.